Viewing Study NCT00528866


Ignite Creation Date: 2025-12-24 @ 4:16 PM
Ignite Modification Date: 2026-02-18 @ 12:17 PM
Study NCT ID: NCT00528866
Status: COMPLETED
Last Update Posted: 2019-04-24
First Post: 2007-09-10
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
Sponsor: Radiation Therapy Oncology Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adenocarcinoma of the prostate View
None stage IIB prostate cancer View
None stage IIA prostate cancer View
None stage III prostate cancer View
None stage IV prostate cancer View